<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">
Log In

SmartTRAK Life Sciences News and Analysis Blog

3 min read

Advancing Orthobiologic Care: Charting a New Course at TOBI 2025

10/14/25 9:29 AM

TOBI2025 V2 copyTOBI President Michael Khadavi, MD, shares his thoughts on the institute's future, key insights from this year’s conference, and exciting new techniques and technologies in the orthobiologics field.  

Dr. Michael Khadavi, a triple-boarded physician in physical medicine and rehab (PM&R), sports medicine, and ultrasound, and the current president of the Orthobiologic Institute (TOBI), discusses the organization's future plans, including expanding its educational programs, research initiatives and strengthening partnerships with industry in an interview with SmartTRAK. Dr. Khadavi also reviews the use of musculoskeletal ultrasound in orthobiologics and highlights the promising results of intraosseous subchondral injections for joint treatments, citing encouraging data from recent studies. Click on the following video (08:22 min) to learn more. A link to download a complete transcript of the interview is also provided below.


SmartTRAK: Hi, this is David Shepard with SmartTRAK. It's my pleasure to be joined by the president of TOBI. This is Dr. Michael Khadavi, triple-boarded physician in PM&R, sports and ultrasound. Thank you very much for joining us.

Michael Khadavi, MD: It is an honor.

Thanks a bunch. So, we're just wrapping up with TOBI, fantastic presentations throughout the week. It's been really, really great. What's your take-home message to all the people that couldn't make it? What are the things that you learned from these last two days? What's the summary of what you learned here?

MK: This was a strong conference, if I've ever been to a good conference. My biggest take-homes are ...

Click the button below to download the full transcript of our exclusive interview with TOBI President Michael Khadavi, MD, conducted by David Shepard, SmartTRAK GM/Sr Analyst, Orthobio & Regen.Get the Transcript


SmartTRAK is the Medtech industry’s only global Insights-as-a-Service solution for the Orthopedics, Wound Care, Regenerative Medicine and Neuro Therapy markets. SmartTRAK’s proprietary methodology turns disparate data from hundreds of sources into powerful insights customers can rely on as the trusted source for strategic decision-making. The SmartTRAK enterprise platform includes rich daily updates, comprehensive market coverage and simple-to-use tools and dashboards for market, product and financial analysis. Customers leveraging the SmartTRAK platform also have direct access to market experts for inquiries and advisory services. If you would like a demo of what SmartTRAK has to offer and see how we can help increase proficiency, improve productivity and reduce costs for your company, just click here...

Topics: Orthobiologics

David Shepard
Written by David Shepard

GM, Orthobiologics & Regenerative Medicine

  • There are no suggestions because the search field is empty.

Follow Us on Social Media

Recent Articles